Karen Shou
Hematology & Oncology · Tripler Amc, HINPI 1265962914
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $665 and has fallen 70.1% since, to $199 in 2025. That places this record below the midpoint for hematology & oncology clinicians in HI, where the typical reported total is $1,482.
Across 56 payments — averaging $27.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$256
- Incyte Corporation$213
- Mirati Therapeutics, Inc.$130
- Karyopharm Therapeutics Inc.$110
- Immunogen, Inc.$109
- Bristol Myers Squibb$94
- plus $626 from 19 others
What the payments were for
- Food & beverage$1,537100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 8 | $256 |
| Incyte Corporation | 7 | $213 |
| Mirati Therapeutics, Inc. | 2 | $130 |
| Karyopharm Therapeutics Inc. | 5 | $110 |
| Immunogen, Inc. | 1 | $109 |
| Bristol Myers Squibb | 4 | $94 |
| E.r. Squibb & Sons, L.L.C. | 2 | $80 |
| GSK | 3 | $66 |
| Amgen | 4 | $61 |
| Exelixis Inc. | 3 | $57 |
| Ipsen Biopharmaceuticals, Inc | 2 | $43 |
| Stemline Therapeutics Inc. | 2 | $38 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $34 |
| Tersera Therapeutics LLC | 1 | $26 |
| Gilead | 1 | $26 |
| AVEO Pharmaceuticals, Inc. | 1 | $24 |
| Seagen Inc. | 1 | $24 |
| Rigel Pharmaceuticals, Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| ADC Therapeutics America, Inc. | 1 | $22 |
| Morphosys, US Inc. | 1 | $21 |
| Servier Pharmaceuticals LLC | 1 | $17 |
| Boehringer Ingelheim | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,537 in reported general payments places this provider in the 50th percentile of 42 hematology & oncology providers in Hawaii.
Other hematology & oncology in Tripler Amc
- Tamie KernsHonolulu$48K
- David TamuraHonolulu$31K
- Melvin PalalayHonolulu$20K
- Ryon NakasoneHonolulu$20K
- Arnold YeeHonolulu$17K
- Jared AcobaHonolulu$15K
- Swaty AroraHonolulu$15K
- Ramin AltahaWailuku$13K
- William LouiHonolulu$12K
- Jodi KagiharaHonolulu$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.